Zai Lab's Series C Round

Zai Lab raised a round of funding on June 28, 2017.

Zai Lab (再鼎医药) (NASDAQ: ZLAB) focuses on discovering, developing and commercializing a pipeline comprised of antibody-based therapies and other protein-based therapeutics that modulates the im…

Articles about Zai Lab's Series C Round: